Kyoung Sook Won

Kyoung Sook Won

Auto-generated profile, based on publicly available information

Kyoung Sook Won

Department of Nuclear Medicine, Keimyung University Dongsan Hospital, Daegu, Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
HKHae Won Kim
Hae Won Kim
KWKyoung Sook Won
Kyoung Sook Won
SZSeok Kil Zeon
Seok Kil Zeon
BAByeong-Cheol Ahn
Byeong-Cheol Ahn
IGIsis W. Gayed
Isis W. Gayed
The study aimed to evaluate the efficacy of PET/CT in detecting peritoneal carcinomatosis in patients with ovarian cancer and to compare the diagnostic accuracy of FDG PET/CT with that of enhanced abdominal CT. The medical records of 46 consecutive patients with ovarian cancer were reviewed, and the presence of peritoneal tumor on (18)F-FDG PET/CT and enhanced abdominal CT scans was also assessed. Imaging results were compared with the pathologic findings obtained by surgery. Pathologic results were positive for peritoneal carcinomatosis in 26 patients and negative in 20 patients. PET/CT correctly detected 25 of 26 patients with peritoneal carcinomatosis and enhanced abdominal CT correctly detected 23 of 26 patients. Sensitivity and specificity for the diagnosis of peritoneal carcinomatosis were 96.2% and 90%, respectively, for PET/CT and 88.5% and 65%, respectively, for enhanced abdominal CT. The accuracy of PET/CT was statistically higher than that of enhanced abdominal CT (93.5% vs 78.3%, P = 0.039). Four distinctly abnormal PET/CT findings of single nodular, multiple nodular, diffuse, and mixed FDG uptakes were identified and corresponded to pathologic findings. (18)F-FDG PET/CT imaging is efficient in the diagnosis of peritoneal carcinomatosis and its performance is superior to that of enhanced abdominal CT.

17 March 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
SKShin Kim
Shin Kim
HYHyon-Ah Yi
Hyon-Ah Yi
KWKyoung Sook Won
Kyoung Sook Won
JLJi Soo Lee
Ji Soo Lee
HKHae Won Kim
Hae Won Kim
The visceral adipose tissue (VAT) has been recognized as an endocrine organ, and VAT dysfunction could be a risk factor for Alzheimer’s disease (AD). We aimed to evaluate the association of VAT metabolism with AD pathology. This cross-sectional study included 54 older subjects with cognitive impairment who underwent 2-deoxy-2-[fluorine-18]-fluoro-D-glucose (18F-FDG) torso positron emission tomography (PET) and 18F-florbetaben brain PET. 18F-FDG uptake in VAT on 18F-FDG PET images was used as a marker of VAT metabolism, and subjects were classified into high and low VAT metabolism groups. A voxel-based analysis revealed that the high VAT metabolism group exhibited a significantly higher cerebral amyloid-β (Aβ) burden than the low VAT metabolism group. In the volume-of-interest analysis, multiple linear regression analyses with adjustment for age, sex, and white matter hyperintensity volume revealed that 18F-FDG uptake in VAT was significantly associated with the cerebral Aβ burden (β = 0.359, p = 0.007). In conclusion, VAT metabolism was associated with AD pathology in older subjects. Our findings suggest that VAT dysfunction could contribute to AD development.

28 April 2012 in Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
SKSung Hoon Kim
Sung Hoon Kim
KWKyoung Sook Won
Kyoung Sook Won
BCByung Wook Choi
Byung Wook Choi
IJIl Jo
Il Jo
SZSeok Kil Zeon
Seok Kil Zeon
JKJung Hyeok Kwon
Jung Hyeok Kwon
This retrospective study investigated the usefulness of F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) after interventional therapy for hepatocellular carcinoma (HCC).

5 November 2020 in Thyroid®
Verified
Journal Article
Closed access
BCByungwook Choi
Byungwook Choi
SKShin Kim
Shin Kim
SKSungmin Kang
Sungmin Kang
KWKyoung Sook Won
Kyoung Sook Won
HYHyon-Ah Yi
Hyon-Ah Yi
HKHae Won Kim
Hae Won Kim
Background: Although several studies have reported an association between thyroid dysfunction and Alzheimer's disease (AD), the effect of mild thyroid dysfunction within the normal range of thyrotropin (TSH) on the development of AD remains unclear. The aim of this study was to evaluate the association between thyroid hormones and the pathology of AD in euthyroid subjects. Methods: Sixty-nine subjects with a TSH level between 0.5 and 4.5 μIU/L who underwent 18 F-florbetaben positron emission tomography were included in this prospective cross-sectional study. The levels of serum free thyroxine (fT4) and TSH were quantified using radioimmunoassay. Neuropsychological tests were performed to assess cognitive function. Differences in cerebral amyloid-β (Aβ) burden were compared between high-normal TSH (TSH ≥2.5 μIU/mL) and low-normal TSH (TSH <2.5 μIU/mL) groups. Multiple linear regression analyses, adjusted for age, sex, education level, and Neuropsychiatric Inventory scores, were performed to evaluate relationships between thyroid hormone levels and both cerebral Aβ burden and cognitive function. Results: The cerebral Aβ burden in the high-normal TSH group was significantly higher than in the low-normal TSH group (1.53 ± 0.31 vs. 1.35 ± 0.22, p = 0.009). The fT4 levels were negatively correlated with cerebral Aβ burden ( β = −0.240, p = 0.035), and TSH levels were positively correlated with cerebral Aβ burden ( β = 0.267, p = 0.020). The fT4 level was also positively associated with cognitive function, as inferred from neuropsychological test scores. Conclusions: Thyroid hormone concentrations were associated with AD pathology in euthyroid subjects. Our findings suggest that AD is likely to occur even in individuals with high-normal TSH levels.

25 February 2015 in Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
HKHae Won Kim
Hae Won Kim
KWKyoung Sook Won
Kyoung Sook Won
BSBong-Il Song
Bong-Il Song
YKYu Na Kang
Yu Na Kang
Histopathologic features could affect the FDG uptake of primary gastric cancer and detection rate on FDG PET/CT. The aim of this study was to evaluate the FDG uptake of primary gastric cancer by correlating it with the histopathologic features of the tumors. Fifty patients with locally advanced gastric adenocarcinoma who were referred for preoperative FDG-PET/CT scans were enrolled in this study. The detection rate of PET/CT and maximum standardized uptake values (SUVmax) of the primary tumor were compared using the WHO, Lauren, Ming and Borrmann classifications and tumor size and location. In 45 of the 50 patients (90 %), the primary gastric tumors were detected by FDG PET/CT. On comparison using the WHO classification, the detection rate and SUVmax of the tubular type were significantly higher than those of the poorly cohesive type. On comparison using the Lauren and Ming classifications, the SUVmaxs of the intestinal type and expanding type were significantly higher than those of the diffuse and infiltrative type, respectively. On comparison using the Borrmann classification and tumor size and location, there was no significant difference in the detection rate and SUVmax of primary gastric tumors. This study demonstrates that the poorly cohesive type according to the WHO classification, diffuse type according to the Lauren classification and infiltrative type according to the Ming classification have low FDG uptake in patients with locally advanced gastric carcinoma. Understanding the relationship between primary tumor FDG uptake and histopathologic features would be helpful in detecting the primary tumor by FDG PET/CT in patients with gastric cancer.

1 January 2003 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
CLChang Hwa Lee
Chang Hwa Lee
KPKeon Uk Park
Keon Uk Park
DNDeuk Young Nah
Deuk Young Nah
KWKyoung Sook Won
Kyoung Sook Won
Lee CH, et al. J Korean Med Sci. 2003 Apr;18(2):277-280. http://dx.doi.org/10.3346/jkms.2003.18.2.277